Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 31 (21) , 5700-5718
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Perlecan Domain IV Peptide Stimulates Salivary Gland Cell Assembly In VitroTissue Engineering Part A, 2009
- Microfabricated Electrospun Collagen Membranes for 3-D Cancer Models and Drug Screening ApplicationsBiomacromolecules, 2009
- Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineeringBiomaterials, 2008
- How Cells Feel Their Environment: A Focus on Early Dynamic EventsCellular and Molecular Bioengineering, 2008
- A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activationMatrix Biology, 2008
- Three-dimensional polymeric systems for cancer cell studiesCytotechnology, 2007
- Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayersBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Mechanical properties of single electrospun drug-encapsulated nanofibresNanotechnology, 2006
- Characterization of nano-structured poly(ε-caprolactone) nonwoven mats via electrospinningPolymer, 2003
- Plasma osteopontinCancer, 2002